The Enterprise Value as of December 2025 (TTM) for Actuate Therapeutics Inc (ACTU) is 153.91M

According to Actuate Therapeutics Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 153.91M. This represents a change of 38.11% compared to the average of 111.45M of the last 4 quarters.

Actuate Therapeutics Inc (ACTU) Historical Enterprise Value (quarterly & annually)

How has ACTU Enterprise Value performed in the past?

The mean historical Enterprise Value of Actuate Therapeutics Inc over the last ten years is 97.96M. The current 153.91M Enterprise Value has changed 15.61% with respect to the historical average. Over the past ten years (40 quarters), ACTU's Enterprise Value was at its highest in in the June 2024 quarter at 174.72M. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

Actuate Therapeutics Inc (ACTU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Actuate Therapeutics Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Actuate Therapeutics Inc (ACTU) Average Enterprise Value

How has ACTU Enterprise Value performed in the past?

The current Enterprise Value of Actuate Therapeutics Inc (ACTU) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Actuate Therapeutics Inc (ACTU) Enterprise Value vs. Peers

How is ACTU’s Enterprise Value compared to its peers?

Actuate Therapeutics Inc’s Enterprise Value is less than Seres Therapeutics, Inc. (194.69M), greater than Spero Therapeutics, Inc. (83.18M), greater than VistaGen Therapeutics, Inc. (78.69M), greater than Applied Therapeutics, Inc. (23.64M), greater than Elicio Therapeutics, Inc. (128.40M), less than Nkarta, Inc. (155.82M), greater than Vor Biopharma Inc. (-100309963.00), greater than Alector, Inc. (82.63M), greater than Molecular Partners AG (46.65M), less than PepGen Inc. (347.79M),

Build a custom stock screener for Actuate Therapeutics Inc (ACTU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Actuate Therapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Actuate Therapeutics Inc (ACTU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Actuate Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.